Molecular Net for Multiplexed Pathogen and Allergen Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic testing strategies are not cost-effective, time-intensive, and limited in scope, making them inefficient for detecting or assessing health or disease-causing factors in mammals, particularly for conditions like MRSA infections and allergic reactions.
Innovation Solution
A layered, multipolymeric molecular net structure is developed, comprising multiple species of capture agents and linking agents that self-assemble to recognize multiple epitopes on analytes, allowing for simultaneous detection of pathogens and allergens without the need for extensive sample preparation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional diagnostic testing strategies are used, then the testing process is well-established and reliable, but the testing is time-intensive and not cost-effective
Solution Approach 1:
The diagnostic testing process is segmented into multiple parallel detection channels, each targeting different analytes (MRSA, allergens, etc.). The molecular net structure is divided into multiple layers with different capture agents, allowing simultaneous detection of multiple targets in a single test run, thereby reducing total testing time while maintaining reliability through distributed detection pathways.
Solution Approach 2:
The molecular net device is designed as a universal platform that can detect multiple types of analytes (bacteria, viruses, allergens, toxins) using the same basic structure. Different capture agents are incorporated into the net layers to provide multi-functionality, allowing a single device to replace multiple specialized tests, reducing time and cost while maintaining diagnostic reliability.
2Adaptability or versatility
If traditional diagnostic testing strategies are used, then the testing protocol is simple and well-established, but the scope of antigen tested is limited
Solution Approach 1:
The detection capability is expanded from a single-dimensional (one analyte per test) to multi-dimensional detection by incorporating multiple layers with different capture agents in the molecular net. This vertical layering allows simultaneous detection of multiple analytes with different specificities, greatly expanding the scope of antigens tested without proportionally increasing protocol complexity.
Solution Approach 2:
The molecular net uses composite structures combining different types of capture agents (antibodies, aptamers, receptors) with linking agents and support matrices. This composite approach enables the device to recognize diverse analytes with different molecular characteristics, expanding testing scope while the modular composite structure keeps the protocol manageable through standardized assembly procedures.
3Measurement precision
If PCR and FISH methods are used for MRSA detection, then nucleic acid detection is achieved, but multiple mutations in target region decrease test sensitivity
Solution Approach 1:
The molecular net incorporates multiple types of capture agents including antibodies that recognize conserved protein structures, aptamers with different binding modes, and receptors that can accommodate various epitope configurations. This multi-functional approach allows the system to maintain high detection sensitivity across different MRSA strains with various mutations, as at least one capture agent type can typically bind to mutated targets.
Solution Approach 2:
The system uses composite capture agent compositions combining different molecular recognition elements (antibodies, aptamers, receptors) with varying specificities. This composite strategy ensures that mutations in nucleic acid target regions do not compromise detection sensitivity, as the protein-based and structure-based recognition mechanisms can accommodate sequence variations while maintaining binding affinity.
4Speed
If lateral flow immunoassay is used, then rapid detection is achieved, but the limit of detection is high due to single epitope binding
Solution Approach 1:
The molecular net segments the detection function across multiple layers, each containing capture agents that bind to different epitopes on the same analyte. This segmentation allows simultaneous engagement of multiple binding sites, amplifying the detection signal and lowering the limit of detection while maintaining the rapid detection speed characteristic of lateral flow formats.
Solution Approach 2:
The system merges multiple binding interactions (multiple capture agents targeting different epitopes) into a single integrated detection platform. This combining of multiple specific binding events enhances the overall signal strength and detection sensitivity, achieving low limits of detection while preserving the rapid processing speed of immunoassay-based lateral flow technology.
5Reliability
If phage-based tests are used, then metabolically active intact cells are required, but this limits sample types and increases preparation complexity
Solution Approach 1:
The system replaces the mechanical/biological requirement for metabolically active cells with molecular recognition elements (antibodies, aptamers, receptors) that can directly bind to analytes. This substitution eliminates the need for complex sample preparation steps to maintain cell viability, allowing direct testing of various sample types while maintaining detection reliability through specific molecular binding.
6Adaptability or versatility
If multiple diagnostic tests are performed for different analytes, then comprehensive detection is achieved, but the cost and time increase significantly
Solution Approach 1:
The molecular net merges multiple diagnostic test functions into a single integrated device structure. Multiple layers with different capture agents are combined in one net, allowing simultaneous detection of multiple analytes (MRSA, allergens, toxins) in a single test run. This merging dramatically improves testing efficiency by reducing the number of separate tests needed while maintaining comprehensive analyte detection coverage.
Solution Approach 2:
The device is designed as a universal multi-functional platform that can detect various analyte types using the same basic molecular net structure. By incorporating diverse capture agents into different net layers, the system achieves broad analyte detection coverage without requiring separate specialized tests for each analyte type, thereby significantly improving overall testing productivity and reducing costs.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables rapid, specific, and sensitive detection of multiple analytes, including MRSA and allergens, reducing the time and cost associated with traditional diagnostic methods while improving the accuracy of results.
Implementation Method 1
comprising multiple species of capture agents and linking agents that self-assemble to recognize multiple epitopes on analytes
Data Source
Figure 1~2
Figure 3
Figure 4A~4B
AI summary
A molecular net formed as a branched pseudorandom copolymer including two broad classes of subunits: capture agents and linking agents. The subunits self-assemble to form a structure capable of binding to predetermined targets. The binding can then be detected.